Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives.

The cardio-ankle vascular index (CAVI) is a new index of the overall stiffness of the artery from the origin of the aorta to the ankle. The most conspicuous feature of CAVI is its independence of blood pressure at the time of measurement.CAVI increases with age and in many arteriosclerotic diseases, such as coronary artery disease, carotid arteriosclerosis, chronic kidney disease and cerebrovascular disease, and is related to many coronary risk factors, such as hypertension, diabetes mellitus, dyslipidemia and smoking. Furthermore, CAVI decreases by controlling diabetes mellitus and hypertension, and also by abstaining from smoking. This suggests that CAVI is a physiological surrogate marker of athero- or arteriosclerosis, and also might be an indicator of lifestyle modification.Recently, it has been reported that CAVI and several left ventricular functions are co-related, suggesting a connection between the heart muscle and vascular function.This review covers the principles of CAVI and our current knowledge about CAVI, focusing on its roles and future outlook.

[1]  J. Staessen,et al.  Clinical applications of arterial stiffness; definitions and reference values. , 2002, American journal of hypertension.

[2]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[3]  A. Hill,et al.  The Velocity of the Pulse Wave in Man , 1922 .

[4]  Tomohiro Kudo,et al.  Relationship between hyperinsulinemia and pulse wave velocity in moderately hyperglycemic patients. , 2003, Diabetes research and clinical practice.

[5]  H. Takane,et al.  Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseases. , 2008, Journal of atherosclerosis and thrombosis.

[6]  T. Ishimitsu,et al.  Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension , 2009, Hypertension Research.

[7]  Hiroshi Ogawa,et al.  Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[8]  K. Shirai,et al.  Changes in cardio-ankle vascular index in smoking cessation. , 2010, Journal of atherosclerosis and thrombosis.

[9]  M. Matsuzaki,et al.  Cardio-Ankle Vascular Index Is Superior to Brachial-Ankle Pulse Wave Velocity as an Index of Arterial Stiffness , 2008, Hypertension Research.

[10]  K. Shirai.  Obesity as the core of the metabolic syndrome and the management of coronary heart disease , 2004, Current medical research and opinion.

[11]  H Handa,et al.  Stiffness and elastic behavior of human intracranial and extracranial arteries. , 1980, Journal of biomechanics.

[12]  T. Oyama,et al.  Contradictory effects of β1- and α1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure. , 2011, Journal of atherosclerosis and thrombosis.

[13]  H. Yagi,et al.  Comparison of Atherosclerotic Indicators Between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity , 2009, Angiology.

[14]  J. Higaki,et al.  Relationship between Cardio-Ankle Vascular Index (CAVI) and Carotid Atherosclerosis in Patients with Essential Hypertension , 2007, Hypertension Research.

[15]  C. Tei,et al.  Association between arterial stiffness and estimated glomerular filtration rate in the Japanese general population. , 2009, Journal of atherosclerosis and thrombosis.

[16]  T. Hamazaki,et al.  Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. , 1988, Atherosclerosis.

[17]  Takanobu Tomaru,et al.  Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[18]  A. Saiki,et al.  Improvement of cardio‐ankle vascular index by glimepiride in type 2 diabetic patients , 2010, International journal of clinical practice.

[19]  H. Miyoshi,et al.  Arterial stiffness is associated with left ventricular diastolic function in patients with cardiovascular risk factors: early detection with the use of cardio-ankle vascular index and ultrasonic strain imaging. , 2007, Journal of cardiac failure.

[20]  K. Kotani,et al.  Comparative study of the cardio-ankle vascular index and ankle–brachial index between young Japanese and Mongolian subjects , 2009, Hypertension Research.

[21]  K. Kotani,et al.  Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[22]  H. Itoh,et al.  Safety and benefits of a tablet combining losartan and hydrochlorothiazide in Japanese diabetic patients with hypertension , 2009, Hypertension Research.

[23]  K. Kotani,et al.  Evaluation of the Cardio-Ankle Vascular Index, a New Indicator of Arterial Stiffness Independent of Blood Pressure, in Obesity and Metabolic Syndrome , 2008, Hypertension Research.

[24]  A. Saiki,et al.  Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. , 2009, Journal of atherosclerosis and thrombosis.

[25]  S. Holewijn,et al.  Pulse wave velocity in familial combined hyperlipidemia. , 2007, American journal of hypertension.

[26]  Y. Miyashita,et al.  Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. , 2009, Journal of atherosclerosis and thrombosis.

[27]  A. Saiki,et al.  Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. , 2009, Journal of atherosclerosis and thrombosis.

[28]  C. Ahn,et al.  Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients. , 2009, Diabetes research and clinical practice.

[29]  K. Kotani,et al.  Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome , 2009, Hypertension Research.

[30]  N. Kohno,et al.  The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects. , 2009, Metabolism: clinical and experimental.

[31]  J. Degaute,et al.  Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation , 2004, Journal of hypertension.

[32]  Y. Nishiyama,et al.  Detection of increased arterial stiffness in a patient with early stage of large vessel vasculitis by measuring cardio-ankle vascular index. , 2009, Tohoku journal of experimental medicine.

[33]  T. Kitawaki,et al.  Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. , 2008, Journal of atherosclerosis and thrombosis.

[34]  Kuniaki Otsuka,et al.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). , 2006, Journal of atherosclerosis and thrombosis.

[35]  A. Saiki,et al.  Effect of ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by cardio-ankle vascular index in type 2 diabetic patients. , 2010, Journal of atherosclerosis and thrombosis.

[36]  R. Asmar.  Pulse wave velocity principles and measurement 25-55 , 1999 .

[37]  Tetsuo Shoji,et al.  Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness , 2009, Journal of hypertension.

[38]  S. Hayashi.  Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness , 2010, International journal of hematology.

[39]  G. Uehara,et al.  Relative Effects of Telmisartan, Candesartan and Losartan on Alleviating Arterial Stiffness in Patients with Hypertension Complicated by Diabetes Mellitus: An Evaluation Using the Cardio-Ankle Vascular Index (CAVI) , 2008, The Journal of international medical research.

[40]  T. Shen,et al.  Use of cardio‐ankle vascular index in chronic dialysis patients , 2011, European journal of clinical investigation.

[41]  Hironori Yamasaki,et al.  Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[42]  K. Murao,et al.  Aortic annular velocity assessed by tissue Doppler echocardiography as a potential parameter of arterial stiffness. , 2010, The Tohoku journal of experimental medicine.

[43]  S Sasayama,et al.  Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. , 1987, Cardiovascular research.

[44]  T. Himoto,et al.  Early detection of hypertension in a patient treated with sunitinib by measuring cardio-ankle vascular index. , 2009, The Tohoku journal of experimental medicine.

[45]  K. Kario,et al.  Comparative study of atherosclerotic parameters in Mongolian and Japanese patients with hypertension and diabetes mellitus. , 2010, Journal of atherosclerosis and thrombosis.

[46]  H. Itoh,et al.  Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-Ankle Vascular Index in Hypertensive Patients , 2010, Kidney and Blood Pressure Research.

[47]  T. Kasai,et al.  Establishment of the cardio-ankle vascular index in patients with obstructive sleep apnea. , 2009, Chest.

[48]  H. Masuda,et al.  Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[49]  A. Saiki,et al.  Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. , 2011, Metabolism: clinical and experimental.

[50]  K. Shirai,et al.  Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients—2-year trial , 1990, Cardiovascular Drugs and Therapy.

[51]  Yukiko Nakano,et al.  Head-to-head comparison of the cardio-ankle vascular index between patients with acute coronary syndrome and stable angina pectoris , 2010, Hypertension Research.

[52]  M. Hasegawa.  Fundamental research on human aortic pulse wave velocity , 1970 .

[53]  A. Hishida,et al.  A Small Reduction in the Ankle-Brachial Index Is Associated with Increased Mortality in Patients on Chronic Hemodialysis , 2009, Nephron Clinical Practice.

[54]  D. Webb,et al.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[55]  E. Nye,et al.  THE EFFECT OF BLOOD PRESSURE ALTERATION ON THE PULSE WAVE VELOCITY , 1964, British heart journal.

[56]  Takayuki Matsumoto,et al.  Possible association of atrophic gastritis and arterial stiffness in healthy middle-aged Japanese. , 2009, Journal of atherosclerosis and thrombosis.

[57]  Akira Nishiyama,et al.  Tissue Doppler echocardiography for predicting arterial stiffness assessed by cardio-ankle vascular index. , 2009, The Tohoku journal of experimental medicine.

[58]  M. Matsuda,et al.  Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[59]  K. Nanjo,et al.  Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. , 2008, Diabetes research and clinical practice.

[60]  A. Saiki,et al.  Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. , 2009, Journal of atherosclerosis and thrombosis.

[61]  T. Kitawaki,et al.  Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. , 2010, Journal of atherosclerosis and thrombosis.

[62]  Yutaka Otsuji,et al.  Clinical significance and reproducibility of new arterial distensibility index. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[63]  Ya-Ru Li,et al.  Effects of personal exposure to particulate matter and ozone on arterial stiffness and heart rate variability in healthy adults. , 2010, American journal of epidemiology.

[64]  H. Itoh,et al.  Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[65]  H. Itoh,et al.  Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome , 2010, Vascular health and risk management.

[66]  Albert Hofman,et al.  Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.

[67]  I. Narita,et al.  Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE). , 2007, Clinica chimica acta; international journal of clinical chemistry.

[68]  Y. Nishiyama,et al.  Cardio-ankle vascular index for evaluating immunosuppressive therapy in a patient with aortitis syndrome. , 2010, The Tohoku journal of experimental medicine.

[69]  C. Tei,et al.  Noninvasive indices of arterial stiffness in hemodialysis patients , 2009, Hypertension Research.

[70]  K. Otsuka,et al.  Cardio-Ankle Vascular Index as a Predictor of Cognitive Impairment in Community-Dwelling Elderly People: Four-Year Follow-Up , 2009, Dementia and Geriatric Cognitive Disorders.